|Bid||168.25 x 200|
|Ask||168.37 x 1100|
|Day's Range||168.21 - 169.36|
|52 Week Range||147.37 - 173.48|
|PE Ratio (TTM)||9.79|
|Expense Ratio (net)||0.25%|
The Zacks Analyst Blog Highlights: Vanguard Small-Cap Growth, iShares S&P Small-Cap 600 Growth and Vanguard S&P Small-Cap 600 Growth
Small-capitalization stock investors were defensive going into the 2017, but they have quickly changed their tune, turning to more growth-weighted smaller company picks. Investors can also gain diversified ...
Eli Lilly’s (LLY) Captisol-enabled drug Prexasertib is currently being evaluated in multiple oncology indications such as head and neck cancer, small-cell lung cancer (or SCLC), and advanced metastatic ...
Ligand Pharmaceuticals (LGND) expects its licensees to invest ~$2.0 billion for advancing more than 155 partnered research and development programs in 2017.
At a time when the U.S. small-cap stocks and exchange traded funds, such as the iShares Core S&P Small-Cap ETF (NYSEArca: IJR) and the iShares Russell 2000 ETF (NYSEArca: IWM) , are trailing large-cap ...
Core Laboratories (CLB) is the largest company by market capitalization among our set of select oilfield services and equipment (or OFS) companies…